Thus, the data support the hypothesis that calpain-1 and CaMKII activity modulation by UB-ALT-EV treatment might improve cell signaling and finally lead to reduced cognitive deficits presented by 5XFAD mice. This evidence concerns the gene CAPN1 and Cognitive impairment.